• 1
    Kurozaka M, Ziff M: Immunoelectron microscopic study of the distribution of T cell subsets in rheumatoid synovium. J Exp Med 158: 11811210, 1983
  • 2
    Smiley JD, Sachs C, Ziff M: In vitro synthesis of immunoglobulin by rheumatoid synovial membrane. J Clin Invest 47: 624632, 1968
  • 3
    Klareskog L, Forsum U, Wigren A, Wigzell H: Relationships between HLA-DR-expressing cells and T cells of different subsets in rheumatoid arthritis synovial tissue. Scand J Immunol 15: 501507, 1982
  • 4
    Hemler ME, Glass D, Coblyn JS, Jacobson JG: Very late activation antigens on rheumatoid synovial fluid T lymphocytes: association with stages of T cell activation. J Clin Invest 78: 696702, 1986
  • 5
    Emery P, Williamson DJ, Mackay IR: The role of cytokines in rheumatological inflammation, Concepts in Immunology, Vol. 4. Edited by JMCruse, RELewis. Basel, Karger, 1987
  • 6
    Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J Exp Med 155: 914923, 1982
  • 7
    Lee F, Yokota T, Otsuka P, Meyerson P, Villaret D, Coffman R, Mosmann T, Rennick D, Roehm N, Zlotnik A, Arai K: Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell and mast-cell-stimulating activities. Proc Natl Acad Sci USA 83: 20612065, 1986
  • 8
    Yokota T, Otsuka T, Mosmann T, Banchereau J, Defiance T, Blanchard D, deVries JE, Lee F, Arai KI: Isolation and characterization of a human interleukin cDNA clone, homologous to mouse BSF-1, which expresses B cell and T cell stimulating activities. Proc Natl Acad Sci USA 83: 58945898, 1986
  • 9
    Defrance T, Vanbervliet B, Aubry JP, Takebe Y, Arai N, Miyajima T, Yokota T, Lee F, Arai K, deVries JE, Banchereau J: B cell growth-promoting activity of recombinant human interleukin 4. J Immunol 139: 11351141, 1987
  • 10
    Spits H, Yssel H, Takebe Y, Arai N, Yokota T, Lee F, Arai KI, Banchereau J, de Vries JE: Recombinant interleukin-4 promotes the growth of human T cells. J Immunol 139: 11421147, 1987
  • 11
    Defrance T, Aubry JP, Rousset F, Vanbervliet B, Bonnefoy JY, Arai N, Takebe YT, Lee F, Arai K, deVries JE, Banchereau J: Human recombinant interleukin 4 induces Fee receptors (CD 23) on normal B lymphocytes. J Exp Med 165: 14591467, 1987
  • 12
    Defrance T, Vanbervliet B, Pene J, Banchereau J: Human recombinant interleukin 4 induces activated B lymphocytes to produce IgG and IgM. J Immunol 141: 20002005, 1988
  • 13
    Paliard X, de Waal Malefijt R, deVries JE, Spits H: Interleukin 4 mediates CD8 induction on human CD4+ T cell clones. Nature 335: 642644, 1988
  • 14
    De Maria A, Malnati M, Moretta A, Pende D, Bottino C, Casorati G, Cottafava G, Melioli G, Mingari MC, Migone N, Romagnani S, Moretta L: CD3+48WT31 (T cell receptor γ+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis: a clonal analysis. Eur J Immunol 17: 18151819, 1987
  • 15
    Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 158
  • 16
    Le HV, Ramanathan L, Labdon JE, Mays-Ichinco CA, Syto R, Arai N, Hoy P, Takebe Y, Nagabhushan TL, Trotta PP: Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells. J Biol Chem 263: 1081710823, 1988
  • 17
    Chretien I, van Kimmenade A, Pearce MK, Banchereau J, Abrams JS: Development of polyclonal and monoclonal antibodies for immunoassay and neutralization of human interleukin 4. J Immunol Methods 117: 6781, 1989
  • 18
    Espevik T, Nissen J Meyer: A highly sensitive cell line WEHI 164 clone 13 for measuring cytotoxic factor/ tumor necrosis factor from human monocytes. J Immunol Methods 95: 99105, 1986
  • 19
    Landegren U: Measurement of cell numbers by means of the endogenous enzyme hexoaminidase: applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67: 379388, 1984
  • 20
    Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB: Immunodetection of the two forms of transforming growth factor beta (TGF-β1 and TGF-β2) secreted by cells in culture. J Cell Physiol 138: 7986, 1989
  • 21
    Miossec P, Kashiwado T, Ziff M: Inhibitor of interleukin-2 in rheumatoid synovial fluid. Arthritis Rheum 30: 121129, 1987
  • 22
    Firestein GS, Zvaifler NJ: Peripheral blood and synovial monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum 30: 864871, 1987
  • 23
    Firestein GS, Xu WD, Townsend K, Broide D, Alvaro-Gracia J, Glasebrook A, Zvaifler NJ: Cytokines in chronic inflammation arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis. J Exp Med 168: 15731586, 1988
  • 24
    Saxne T, Palladino MA Jr Heinegård D, Talal N, Wollheim FA: Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 31: 10411045, 1988
  • 25
    Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T: Active and latent forms of transforming growth factor β activity in synovial effusions. J Exp Med 169: 291296, 1989
  • 26
    Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Shimizu M, Maini R, Feldmann M, Kishimoto T: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 17971801, 1988
  • 27
    Kashiwado T, Miossec P, Oppenheimer-Marks N, Ziff M: Inhibitor of interleukin-2 synthesis and response in rheumatoid synovial fluid. Arthritis Rheum 30: 13391347, 1987
  • 28
    Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynk R, Sporn MB, Fauci AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 163: 10371050, 1986
  • 29
    Huang SS, O'Grady P, Huang JS: Human transforming growth factor β-α2-macroglobulin complex is a latent form of transforming growth factor β. J Biol Chem 263: 15351541, 1988
  • 30
    Dupuy d'Angeac A, Travo C, Miossec P, Julien P: Transforming growth factor β, platelet-derived growth factor and fibroblast growth factor in synovial fluids of patients with rheumatoid arthritis (abstract). Arthritis Rheum 32 (suppl 4): S56, 1989
  • 31
    Lafyatis R, Thompson NL, Remmers EF, Flanders KC, Roche NS, Kim SJ, Case JP, Sporn MB, Roberts AB, Wilder RL: Transforming growth factor-β production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats: studies on secretion by synovial fibroblast-like cells and immunohistologic localization. J Immunol 143: 11421148, 1989
  • 32
    Flescher E, Bowlin TL, Ballester A, Houk R, Talal N: Increased polyamines may downregulate interleukin 2 production in rheumatoid arthritis. J Clin Invest 83: 13561362, 1989
  • 33
    Cush JJ, Lipsky PE: Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 31: 12301238, 1988
  • 34
    Salmon M, Kitas GD, Emery P: Another interpretation of the role of T helper cells in the rheumatoid synovium. Arthritis Rheum 32: 795796, 1989
  • 35
    Defrance T, Vanbervliet B, Durand I, Banchereau J: Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Eur J Immunol 19: 293299, 1989
  • 36
    Nathan CF: Secretory products of macrophages. J Clin Invest 79: 319326, 1987
  • 37
    Horii Y, Muraguchi A, Suematsu S, Masuda T, Yoshizaki K, Hirano T, Kishimoto T: Regulation of BSF-2/IL-6 production by human mononuclear cells: macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 141: 15291535, 1988
  • 38
    Sung S-SJ Jung LKL, Walters JA, Chen W, Wang CY, Fu SM: Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J Exp Med 168: 15391551, 1988